Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Buy
7,965
+885
+13% +$59K 0.03% 436
2026
Q1
$445K Buy
+7,080
New +$493K 0.03% 428
2024
Q3
Sell
-2,858
Closed -$324K 627
2024
Q2
$324K Sell
2,858
-25,475
-90% -$3.22M 0.1% 104
2024
Q1
$3.69M Buy
+28,333
New +$3.56M 0.3% 77

Other funds holding DXCM

NWAM LLC's DXCM Position: Q2 2026 in Review

NWAM LLC increased its DexCom (DXCM) stake by 13% in Q2 2026, buying an estimated $59K and bringing the position to 7,965 shares worth $536K. The position accounts for 0.03% of the portfolio, ranked #436.

NWAM LLC first reported a position in DXCM in Q1 2024 and has held it in 4 quarters since. The position peaked at $3.69M in Q1 2024. 972 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • NWAM LLC held 7,965 shares of DexCom worth $536K as of Q2 2026.
  • NWAM LLC bought 885 DexCom shares in Q2 2026, an estimated $59K.
  • DexCom made up 0.03% of NWAM LLC's portfolio in Q2 2026, its #436 holding.
  • NWAM LLC first reported a position in DexCom in Q1 2024 and has held it in 4 quarters since.
  • NWAM LLC's DexCom position peaked at $3.69M in Q1 2024.
  • 972 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.